These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Measurement of the extraction fractions of nanocolloid and polyclonal immunoglobulin by axillary lymph nodes in patients with breast cancer. Fowler JC, Solanki CK, Barber RW, Swift EA, Guenther I, Ballinger JR, Purushotham AD, Peters AM. Nucl Med Commun; 2004 Sep; 25(9):935-40. PubMed ID: 15319599 [Abstract] [Full Text] [Related]
6. Subareolar injection of technetium-99m nanocolloid yields reliable data on the axillary lymph node tumour status in breast cancer patients with previous manipulations on the primary tumour: a prospective study of 117 patients. Maza S, Thomas A, Winzer KJ, Hüttner C, Blohmer JU, Hauschild M, Richter M, Krössin T, Geworski L, Zander A, Guski H, Munz DL. Eur J Nucl Med Mol Imaging; 2004 May; 31(5):671-5. PubMed ID: 14745517 [Abstract] [Full Text] [Related]
11. The effect of radiocolloid preference on major parameters in sentinel lymph node biopsy practice in breast cancer. Yararbas U, Argon AM, Yeniay L, Zengel B, Kapkaç M. Nucl Med Biol; 2010 Oct; 37(7):805-10. PubMed ID: 20870155 [Abstract] [Full Text] [Related]
19. Comparison of Tc-99m MDP, Tc-99m HSA and Tc-99m HIG uptake in rheumatoid arthritis and its variants. Sahin M, Bernay I, Basoglu T, Canturk F. Ann Nucl Med; 1999 Dec; 13(6):389-95. PubMed ID: 10656272 [Abstract] [Full Text] [Related]